Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial.
暂无分享,去创建一个
T. Wilson | N. Harbeck | V. Diéras | N. Cui | W. Jacot | S. Dent | J. Cortés | I. Krop | J. Hsu | P. Drullinsky | S. Sousa | Y. Im | M. Laurentiis | J. He | F. Schimmoller | M. de Laurentiis | J. He | Nadia Harbeck | Susan Dent | Yunjoo Im | Na Cui | Jing He | W. Jacot | T. Wilson